Bendamustine Hydrochloride Injection 100 mg/vial

Here is the detailed overview of Bendamustine Hydrochloride Injection 100 mg/vial with icons:


💉 Bendamustine Hydrochloride Injection 100 mg/vial


🧪 Nature / Drug Class

🔹 Anticancer (Chemotherapy) Agent
🔹 Alkylating agent with purine analog properties
🔹 Causes DNA cross-linking, leading to cell cycle arrest and tumor cell death


🩺 Purpose / Indications

✅ Used in the treatment of:

  • 🧬 Chronic Lymphocytic Leukemia (CLL)
  • 🦠 Indolent Non-Hodgkin’s Lymphoma (iNHL)
  • 🔁 Off-label: Multiple myeloma, Mantle cell lymphoma, Hodgkin’s lymphoma (under oncologist supervision)

⚙️ Advantages

✔️ Effective in first-line and relapsed settings
✔️ Can be combined with rituximab or other agents
✔️ Suitable for patients not responding to other therapies
✔️ Short infusion time compared to some other regimens


📦 Common Packaging

📦 Vial contains 100 mg of Bendamustine hydrochloride
💉 Supplied as lyophilized powder for IV reconstitution
🧪 Also available in 25 mg vials for flexible dosing


⚠️ Patient Advice / Precautions

🧪 Reconstitute with Sterile Water for Injection
💧 Dilute in 0.9% Sodium Chloride (Normal Saline)
⏱️ IV infusion over 30–60 minutes, usually on Day 1 & Day 2 of 28-day cycles
📋 Monitor closely for:

  • 🩸 Myelosuppression (neutropenia, anemia, thrombocytopenia)
  • 🧫 Infections, tumor lysis syndrome
  • 🧪 Liver & kidney function
    🚫 Not for intrathecal administration
    🚼 Contraindicated in pregnancy and breastfeeding

🧊 Storage

🌡️ Store vial at 2–8°C (Refrigerated)
💉 After reconstitution: Use immediately or as per manufacturer’s stability guidelines
🧒 Keep away from children


Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button